Clinical Trials for Lung Cancers

22 Open Trials

Trial Type &
Disease
Protocol No. &
Open Date
Summary
Basic Science
Lung;
Non Small Cell
VICCTHN1164
11/04/2011
Molecular Profiles for Lung Cancer Pathogenesis and Detection
Basic Science
Lung
VICCTHO0967
07/27/2010
Lung Cancer Mutation Consortium Protocol
Basic Science
Lung;
Non Small Cell
VICCTHO0547
12/19/2005
Molecular Fingerprints in Lung Cancer: Predicting Tumor Response to Therapy (SPORE)
Basic Science
Lung
VICCTHO0398
12/04/2003
Molecular Predictors of Lung Cancer Behavior. (SPORE)
Basic Science
Lung
VICCTHO0373
05/03/2001
Identification and Validation of Molecular Markers in Lung Cancer (SPORE)
Diagnostic
Lung;
Miscellaneous
VICCTHO1078
04/12/2011
Nashville Early Diagnosis Lung Cancer Project
Other
Lung
VICCTHN1291
03/28/2013
Early Diagnosis of Pulmonary Nodules Using a Plasma Proteomic Classifier
Other
Lung
VICCTHN1292
03/18/2013
Validation of Molecular Biomarkers for the Early Detection of Lung Cancer in the Setting of Indeterminate Pulmonary Nodules. (Lung Team Project #2)
Supportive Care
Breast;
Colon;
Lung;
Prostate;
Rectal
VICCREACH1341
09/05/2013
Using a Tailored Navigation Intervention to Prepare Patients and Their Support Person for the Journey at Time of Cancer Diagnosis and at Transition into Survivorship
Treatment
Lung;
Non Small Cell
VICCTHN12106
03/12/2014
A Phase 1/2, Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of Oral CO-1686 in Patients with Previously Treated Mutant EGFR Non-Small Cell Lung Cancer (NSCLC)
Treatment
Lung
VICCTHN1379
02/21/2014
A Phase III, Double-Blind, Randomised, Placebo-Controlled Study to Assess the Efficacy and Safety of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Combination with Docetaxel, in Patients receiving second line treatment for KRAS Mutation-Positive Locally Advanced or Metastatic Non Small Cell Lung Cancer (Stage IIIB/IV) (SELECT-1)
Treatment
Breast;
Gastric/Gastroesophageal;
Lung;
Pancreatic
VICCPHI1359
12/03/2013
A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors
Treatment
Lung
VICCTHNP1353
10/30/2013
A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD9291 in Patients with Advanced Non Small Cell Lung Cancer who have Progressed Following Prior Therapy with an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Agent (AURA)
Treatment
Lung;
Non Small Cell
VICCTHN1307
06/06/2013
A Phase 2 Study of Neratinib and Neratinib Plus Temsirolimus in Patients with Non-Small Cell Lung Cancer Carrying Known HER2 Activating Mutations
Treatment
Lung;
Small Cell
VICCTHN1189
12/14/2012
Randomized, Multicenter, Double-Blind, Phase 3 Trial Comparing the Efficacy of Ipilimumab plus Etoposide/Platinum versus Etoposide/Platinum in Subjects with Newly Diagnosed Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC)
Treatment
Lung;
Non Small Cell
VICCTHN1242
10/24/2012
A Phase IB, Multi-Center,Open-Label Study of the MTOR Kinase Inhibitor CC-223 in Combination with Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer
Treatment
Adrenocortical;
Bladder;
Breast;
Cervical;
Colon;
Dermatologic;
Esophageal;
GIST;
Gastric/Gastroesophageal;
Gynecologic;
Head/Neck;
Kidney (Renal Cell);
Liver;
Lung;
Multiple Myeloma;
Neuroendocrine;
Ovarian;
Pancreatic;
Prostate;
Rectal;
Sarcoma;
Small Cell;
Uterine
VICCMD1188
06/08/2012
An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
Treatment
Lung;
Non Small Cell
ECOGTHNE5508
06/29/2011
Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Premetrexed, or Combination of Bevacizumab and Premtrexed following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
Treatment
Non Small Cell
ECOGTHO5508-M
02/09/2011
Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
Treatment
Lung
ECOGTHO4508-M
12/07/2010
Three-Arm Randomized Phase II Study of Carboplatin and Paclitaxel in Combination with Cetuximab, IMC-A12 or Both for Advanced Non-small Cell Lung Cancer Patients WhoWill Not Receive Bevacizumab-based Therapy
Treatment
Lung
CTSUTHOC30607-M
02/17/2010
ARandomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Patients following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer
Treatment
Non Small Cell
ECOGTHOE1505-M
07/27/2007
A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB (> or = 4 cm)- IIIA Non-Small Cell Lung Cancer (NSCLC)

You do not have JavaScript enabled. This site works better with JavaScript turned on.